Pediatric Study Requests Would Benefit From Input On Trial Design – Cmte.
Executive Summary
FDA hopes that internal process improvements will result in "more clever" requests to companies for pediatric studies under the Best Pharmaceuticals for Children Act
You may also be interested in...
Senate HELP Committee Leadership: Sizing Up The Candidates
Sen. Chris Dodd has a relatively limited record in pharmaceutical legislation - especially in comparison to the late Sen. Ted Kennedy - but his initiatives include establishing incentives for pediatric drug development and supporting increased government oversight in the areas of drug safety and direct-to-consumer advertising
Senate HELP Committee Leadership: Sizing Up The Candidates
Sen. Chris Dodd has a relatively limited record in pharmaceutical legislation - especially in comparison to the late Sen. Ted Kennedy - but his initiatives include establishing incentives for pediatric drug development and supporting increased government oversight in the areas of drug safety and direct-to-consumer advertising
Senate HELP Committee Leadership: Sizing Up The Candidates
Regardless who is chosen as chairman, the committee will undoubtedly feel in the near-term the absence of a champion of federal health programs - one who is both forceful in demeanor and expert in the detailed workings and policy history of a variety of initiatives.